Back
Targeting Disease Modification in Psoriasis and Psoriatic Arthritis
Medical experts explore evidence-based strategies to decelerate the progression of psoriasis and psoriatic arthritis, aiming to optimize patient outcomes and enhance long-term disease management.
Targeting Disease Modification in Psoriasis and Psoriatic Arthritis
Episodes
All
All
Please check back later for more content.
Advertisement
Advertisement
Trending on HCPLive
1
Phase 3 Ritlecitinib Results in Vitiligo, With Iltefat Hamzavi, MD
2
EADV Congress 2026: Day 3 Recap—5 Headlines to Know
3
AMETHYST: Litifilimab Sustains CLE Gains at 52 Weeks, With Victoria Werth, MD
4
The Liver Keeps the Score: Americans Are Drinking Less, but Alcohol-Associated Liver Disease May Lag
5